Needed: Big Improvement In Diabetes Caree

Published Online: Wednesday, May 1, 2002

A wide gap ?exists in the United States between our knowledge of effective diabetes interventions and their implementation in practice.? That?s the conclusion of a report published in the April 2002 issue of the Annals of Internal Medicine. Based on two major surveys of diabetics conducted between 1988 and 1995, the report presents the first national picture of diabetes care. Among diabetics, the following results were found:

  • 18% had inadequate blood sugar control
  • 34% had poor blood pressure control
  • 58% had insufficient cholesterol control

In addition, 37% did not have the annual eye examinations that are essential to detecting vision-loss conditions associated with diabetes. Also, 45% did not havethe annual foot examinations needed to help detect conditions that can lead to amputation.  On the positive side, Dr. Francine R. Kaufman, president-elect of the American Diabetes Association, predicts that the next round of data will show important gains. ?We?ve been hauled into the principal?s office, and we?re doing better,? she says.

Latest Articles
The FDA has approved Boehringer Ingelheim’s oral direct thrombin inhibitor dabigatran etexilate mesylate (Pradaxa) for the prophylaxis of deep vein thrombosis and pulmonary embolism in patients who have had hip replacement surgery.
As a result of implementation difficulties, the FDA announced that it will extend the pharmacy certification deadline for the clozapine risk evaluation and mitigation strategy program.
Pharmacies are rated as some of the best places to receive top-notch customer service in America.
Often caused by acid reflux, eosinophilic esophagitis is an emerging inflammatory disease that is generally unresponsive to proton pump inhibitor therapy.
Latest Issues